Medical costs of Swedish nursing home residents at the end of life : a retrospective observational registry study

Article

SALAJ, Dag | SCHULTZ, Torbjörn | STRANG, Peter M.

BACKGROUND: There are many studies of medical costs in late life in general, but nursing home residents' needs and the costs of external medical services and interventions outside of nursing home services are less well described. METHODS: We examined the direct medical costs of nursing home residents in their last year of life, as well as limited to the period of stay in the nursing home, adjusted for age, sex, Hospital Frailty Risk Score (HFRS), and diagnosis of dementia or advanced cancer. This was an observational retrospective study of registry data from all diseased nursing home residents during the years 2015-2021 using healthcare consumption data from the Stockholm Regional Council, Sweden. T tests, Wilcoxon rank sum tests and chi-square tests were used for comparisons of groups, and generalized linear models (GLMs) were constructed for univariable and multivariable linear regressions of health cost expenditures to calculate risk ratios (RRs) with 95% confidence intervals (95% CIs). RESULTS: According to the adjusted (multivariable) models for the 38,805 studied nursing home decedents, when studying the actual period of stay in nursing homes, we found significantly greater medical costs associated with male sex (RR 1.29 (1.25–1.33), p < 0.0001) and younger age (65–79 years vs. =90 years: RR 1.92 (1.85–2.01), p < 0.0001). Costs were also greater for those at risk of frailty according to the Hospital Frailty Risk Score (HFRS) (intermediate risk: RR 3.63 (3.52–3.75), p < 0.0001; high risk: RR 7.84 (7.53–8.16), p < 0.0001); or with advanced cancer (RR 2.41 (2.26–2.57), p < 0.0001), while dementia was associated with lower medical costs (RR 0.54 (0.52–0.55), p < 0.0001). The figures were similar when calculating the costs for the entire last year of life (regardless of whether they were nursing home residents throughout the year). CONCLUSIONS: Despite any obvious explanatory factors, male and younger residents had higher medical costs at the end of life than women. Having a risk of frailty or a diagnosis of advanced cancer was strongly associated with higher costs, whereas a dementia diagnosis was associated with lower external, medical costs. These findings could lead us to consider reimbursement models that could be differentiated based on the observed differences.

http://dx.doi.org/10.1186/s12877-024-05043-9

Voir la revue «BMC GERIATRICS, 24»

Autres numéros de la revue «BMC GERIATRICS»

Consulter en ligne

Suggestions

Du même auteur

Nursing home residents with dementia at end o...

Article indépendant | SALAJ, Dag | JOURNAL OF PALLIATIVE MEDICINE | n°1 | vol.27

Background: Most nursing home (NH) residents do not benefit from health care at an emergency room (ER) or inpatient care at an emergency hospital during the end-of-life period. Therefore, a low number of unplanned admissions durin...

Nursing home residents with dementia at end o...

Article indépendant | SALAJ, Dag | JOURNAL OF PALLIATIVE MEDICINE | n°1 | vol.27

Background: Most nursing home (NH) residents do not benefit from health care at an emergency room (ER) or inpatient care at an emergency hospital during the end-of-life period. Therefore, a low number of unplanned admissions durin...

Medical costs of Swedish nursing home residen...

Article indépendant | SALAJ, Dag | BMC GERIATRICS | n°1 | vol.24

BACKGROUND: There are many studies of medical costs in late life in general, but nursing home residents' needs and the costs of external medical services and interventions outside of nursing home services are less well described. ...

De la même série

Dying in residential care homes during the ea...

Article | PRESTON, Nancy | BMC GERIATRICS | n°1 | vol.25

BACKGROUND: Early in the COVID-19 pandemic, care homes (long-term care facilities) globally were severely impacted in many ways, including end-of-life care and death of residents. They experienced significantly elevated mortality ...

Palliative use of midazolam in acute geriatri...

Article | PROD'HOMME, Chloé | BMC GERIATRICS | n°1 | vol.25

INTRODUCTION: End-of-life management in acute geriatric units (AGUs) is frequent but complex. Midazolam is the drug of choice for the management of refractory symptoms (particularly in the context of sedation) at the end of life. ...

Implementing advance care planning in palliat...

Article | WILKIN, Katie | BMC GERIATRICS | n°1 | vol.24

BACKGROUND: Advance care planninganning (ACP) is a priority within palliative care service provision. Nurses working in the community occupy an opportune role to engage with families and patients in ACP. Carers and family members ...

Chinese older adults' prior-to-death disabili...

Article | CHEN, Chuqian | BMC GERIATRICS | n°1 | vol.24

BACKGROUND: Disability prior to death complicates end-of-life care. The present study aimed to explore the prior-to-death disability profiles of Chinese older adults, the profiles' links to end-of-life care arrangements and place ...

Evaluation of a knowledge-attitude-practice m...

Article | XIE, Xifeng | BMC GERIATRICS | n°1 | vol.24

Background: The global aging population presents challenges that are particularly acute in China. Older Chinese adults’ attitudes towards death significantly impact their quality of life. Death education is crucial for promo...

Chargement des enrichissements...